41 results
Page 2 of 3
8-K
EX-99.1
24iiup40
12 Jun 23
Regulation FD Disclosure
8:07am
8-K
EX-99.1
3o3urjv2qa4u7l
5 Jun 23
Regulation FD Disclosure
6:08am
8-K
EX-99.2
kurjyt
1 May 23
Day One Reports First Quarter 2023 Financial Results and Corporate Progress
9:01am
8-K
EX-99.2
e896cofsc xl
7 Nov 22
Day One Reports Third Quarter 2022 Financial Results and Corporate Progress
4:31pm
8-K
EX-99.2
a7n yidh4tx5uf33im0v
12 Sep 22
Day One Appoints Garry Nicholson as Chairman of the Board of Directors
8:40am
8-K
EX-99.2
52gm9lvub2
4 Aug 22
Day One Reports Second Quarter 2022 Financial Results and Corporate Progress
4:53pm
8-K
EX-99.1
xffuo
24 Jun 22
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
EX-99.2
058gg
13 Jun 22
Day One Announces Positive Initial Data from Pivotal FIREFLY-1 Trial of Tovorafenib (DAY101) in Relapsed Pediatric Low-Grade Glioma
6:24am
DEF 14A
5s2b8l4c4
28 Apr 22
Definitive proxy
4:44pm
10-K
zv5f35
7 Mar 22
Annual report
7:36am
10-Q
1239bter
10 Aug 21
Quarterly report
5:26pm
424B4
3obx7g2r5qcl
27 May 21
Prospectus supplement with pricing info
4:18pm
S-1/A
i5yt8shyesgk
24 May 21
IPO registration (amended)
6:16am
S-1
a2l gyvrtg6slcd965
4 May 21
IPO registration
4:12pm